REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,235,200 | +89.5% | 120,000 | +69.0% | 1.52% | +16.5% |
| Q1 2023 | $6,455,320 | +99.9% | 71,000 | -16.5% | 1.30% | +91.7% |
| Q4 2022 | $3,229,150 | +1.8% | 85,000 | -18.6% | 0.68% | +4.0% |
| Q2 2022 | $3,172,000 | +176.5% | 104,369 | +198.2% | 0.65% | +118.8% |
| Q1 2022 | $1,147,000 | -57.8% | 35,000 | -66.0% | 0.30% | -60.4% |
| Q4 2021 | $2,716,000 | -22.9% | 103,000 | +194.3% | 0.75% | -25.7% |
| Q3 2021 | $3,521,000 | -40.8% | 35,000 | -16.7% | 1.01% | -38.1% |
| Q2 2021 | $5,944,000 | +35.5% | 42,000 | -4.5% | 1.64% | +30.6% |
| Q1 2021 | $4,387,000 | -29.0% | 44,000 | -12.0% | 1.25% | -31.8% |
| Q4 2020 | $6,181,000 | +58.6% | 50,000 | +25.0% | 1.84% | +54.2% |
| Q3 2020 | $3,897,000 | – | 40,000 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |